loading page

Screening for Olfactory Dysfunction in COVID-19 Patients Using Quick Smell Identification Test
  • +3
  • Hussain Albaharna,
  • Alya Alhajjaj,
  • Hussain Al Shabeb,
  • Dhuha Alghanim,
  • Fatimah Alkhabbaz,
  • Jumana AlJishi
Hussain Albaharna
Qatif Central Hospital
Author Profile
Alya Alhajjaj
Qatif Central Hospital
Author Profile
Hussain Al Shabeb
Qatif Central Hospital
Author Profile
Dhuha Alghanim
Qatif Central Hospital
Author Profile
Fatimah Alkhabbaz
Qatif Central Hospital
Author Profile
Jumana AlJishi
Qatif Central Hospital
Author Profile

Abstract

Intro: To determine the prevalence of OD in the confirmed case with COVID-19 among our population using quick smell identification test (Q-SIT) as screening tool. Methods: Cross- sectional study carried out in Qatif area – Saudi Arabia among adult hospitalized patient with confirm COVID-19 during the period between May and July, 2020. All adults confirmed COVID-19 patients were interviewed for history of current disease and associated symptoms as well as performing Q-SIT. Participants who had history of olfactory dysfunction, and critical cases required ICU admission were excluded. Results: The prevalence of OD among COVID-19 cases was (16.3%) in our population using Q-SIT compared to (27.4%) for self-reported symptom. Females were having higher prevalence in compare to males (30.5% and 11.1%) respectively; which was statistically significant (P <0.001). The patients reported higher prevalence of ageusia (31.9%) with significant association with OD (P <0.001). Q-SIT showed high positive and negative predictive value in detecting OD among patients with COVID-19 (84% and 93% respectively). Conclusion: Q-SIT is a useful, validated and easy to apply tool for screening OD among patients with COVID-19. Some patients presented solely with this symptom which can occurs unnoticed in COVID-19 patients, and there for required objective test for detection.